hydrocodone/acetaminophen
Phase 3Small molecule
AbbViehydrocodone/acetaminophen is one of 63 small molecule programs targeting Anxiety. It is currently in Phase 3.
3
Indications
23
Total Trials
2
Active Trials
62
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
61 competitors in Anxiety
#DrugCompanyPhaseTrials
1Versed
CConrado Roberto Hoffmann Filho
Approved
Lexapro
AbbVieApproved
Cymbalta
Jazz PharmaceuticalsApproved
Neupro
UCBApproved
Buspar
Bristol-Myers SquibbApproved
Xanax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Lyrica
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
Namenda
AbbVieApproved
Zoloft
VViatris Specialty LLC
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Acetaminophen4 trials
Acute Pain2 trials
Toothache1 trial
The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache
Completed·—·Phase 4·NCT00574015·18 enrolled
13 more indications
Humerus Fracture1 trial
Post-operative Pain Management in Children With Supracondylar Humerus Fractures
Terminated·—·Phase 4·NCT05640674·29 enrolled
Mucositis1 trial
Anxiety1 trial
Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair
Completed·—·N/A·NCT01053637·85 enrolled
Non-Opioid Pain Management1 trial
SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management
Active, not recruiting·—·Phase 4·NCT06187584·160 enrolled
Perioperative Pain Control1 trial
Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
Unknown status·UUniversity of Illinois College of Medicine at Peoria·Phase 4·NCT02958566·80 enrolled
Osteoarthritis1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for hydrocodone/acetaminophen. EMBL-EBI & Wellcome Sanger Institute.
- [4]